TRVN - トレベナ (Trevena Inc.)

TRVNのニュース

   Earnings Scheduled For November 2, 2020  2020/11/02 12:55:36 Benzinga
Companies Reporting Before The Bell • Itron (NASDAQ: ITRI ) is likely to report quarterly earnings at $0.25 per share on revenue of $540.01 million. • AMC Networks (NASDAQ: AMCX ) is projected to report quarterly earnings at $1.28 per share on revenue of $606.04 million. • BWX Technologies (NYSE: BWXT ) is likely to report quarterly earnings at $0.68 per share on revenue of $499.24 million. • Clorox (NYSE: CLX ) is projected to report quarterly earnings at $2.32 per share on revenue of $1.75 billion. • Camping World Holdings (NYSE: CWH ) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.51 billion. • Eagle Pharmaceuticals (NASDAQ: EGRX ) is likely to report quarterly earnings at $0.28 per share on revenue of $47.02 million. • Exterran (NYSE: EXTN ) is likely to report quarterly loss at $0.48 per share on revenue of $194.32 million. • FirstEnergy (NYSE: FE ) is likely to report quarterly earnings at $0.76 per share on revenue of $2.94 billion. • MGM Growth Properties (NYSE: MGP ) is expected to report quarterly earnings at $0.
   Athersys (NASDAQ:ATHX) and Trevena (NASDAQ:TRVN) Head to Head Analysis  2020/10/21 11:18:54 Zolmax News
Athersys (NASDAQ:ATHX) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings. Earnings & Valuation This table compares Athersys and Trevena’s top-line revenue, earnings per share and valuation. Gross […]
   Trevena Inc (NASDAQ:TRVN) Short Interest Update  2020/10/21 09:26:42 Dakota Financial News
Trevena Inc (NASDAQ:TRVN) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 17,340,000 shares, a growth of 16.9% from the September 15th total of 14,830,000 shares. Based on an average daily volume of 11,560,000 shares, the short-interest ratio is currently […]
   The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September  2020/08/11 12:20:27 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR ) BioLife Solutions Inc (NASDAQ: BLFS ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (reacted to second-quarter results) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Fulgent Genetics Inc (NASDAQ: FLGT ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Omeros Corporation (NASDAQ: OMER ) ( announced positive results for the study of its lead asset in COVID-19) Pacira Biosciences Inc (NASDAQ: PCRX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) ( reacted to positive late-stage clinical readout) Silk Road Medical Inc (NASDAQ: SILK ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) (announced FDA nod for pain drug) Unity Biotechnology Inc (NASDAQ: UBX ) Vaxcyte Inc (NASDAQ: PCVX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 10) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) (went public Friday) Freeline Therapeutics Holdings plc ADS (NASDAQ: FRLN ) (went public Friday) Lantern Pharma Inc. (NASDAQ: LTRN ) Nkarta Inc (NASDAQ: NKTX ) Recro Pharma Inc (NASDAQ: REPH ) (reacted to second-quarter results) Stocks In Focus Equillium Announces Positive Interim Data For Lead Drug, Requests Pre-IND Meeting For COVID-19 Study Equillium Inc (NASDAQ: EQ ) announced positive interim data from the first two cohorts of the Phase 1b open label, dose escalation portion of the EQUATE study of itolizumab in acute graft-versus-host disease.
   Wichtige Kursbewegungen: Schmerzmittel-Zulassung sorgt bei Trevena für Euphorie  2020/08/10 12:27:00 BORSE ONLINE
Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:
   Earnings Scheduled For November 2, 2020  2020/11/02 12:55:36 Benzinga
Companies Reporting Before The Bell • Itron (NASDAQ: ITRI ) is likely to report quarterly earnings at $0.25 per share on revenue of $540.01 million. • AMC Networks (NASDAQ: AMCX ) is projected to report quarterly earnings at $1.28 per share on revenue of $606.04 million. • BWX Technologies (NYSE: BWXT ) is likely to report quarterly earnings at $0.68 per share on revenue of $499.24 million. • Clorox (NYSE: CLX ) is projected to report quarterly earnings at $2.32 per share on revenue of $1.75 billion. • Camping World Holdings (NYSE: CWH ) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.51 billion. • Eagle Pharmaceuticals (NASDAQ: EGRX ) is likely to report quarterly earnings at $0.28 per share on revenue of $47.02 million. • Exterran (NYSE: EXTN ) is likely to report quarterly loss at $0.48 per share on revenue of $194.32 million. • FirstEnergy (NYSE: FE ) is likely to report quarterly earnings at $0.76 per share on revenue of $2.94 billion. • MGM Growth Properties (NYSE: MGP ) is expected to report quarterly earnings at $0.
   Athersys (NASDAQ:ATHX) and Trevena (NASDAQ:TRVN) Head to Head Analysis  2020/10/21 11:18:54 Zolmax News
Athersys (NASDAQ:ATHX) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings. Earnings & Valuation This table compares Athersys and Trevena’s top-line revenue, earnings per share and valuation. Gross […]
   Trevena Inc (NASDAQ:TRVN) Short Interest Update  2020/10/21 09:26:42 Dakota Financial News
Trevena Inc (NASDAQ:TRVN) was the recipient of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 17,340,000 shares, a growth of 16.9% from the September 15th total of 14,830,000 shares. Based on an average daily volume of 11,560,000 shares, the short-interest ratio is currently […]
   The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September  2020/08/11 12:20:27 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR ) BioLife Solutions Inc (NASDAQ: BLFS ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (reacted to second-quarter results) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Fulgent Genetics Inc (NASDAQ: FLGT ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Omeros Corporation (NASDAQ: OMER ) ( announced positive results for the study of its lead asset in COVID-19) Pacira Biosciences Inc (NASDAQ: PCRX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) ( reacted to positive late-stage clinical readout) Silk Road Medical Inc (NASDAQ: SILK ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) (announced FDA nod for pain drug) Unity Biotechnology Inc (NASDAQ: UBX ) Vaxcyte Inc (NASDAQ: PCVX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 10) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) (went public Friday) Freeline Therapeutics Holdings plc ADS (NASDAQ: FRLN ) (went public Friday) Lantern Pharma Inc. (NASDAQ: LTRN ) Nkarta Inc (NASDAQ: NKTX ) Recro Pharma Inc (NASDAQ: REPH ) (reacted to second-quarter results) Stocks In Focus Equillium Announces Positive Interim Data For Lead Drug, Requests Pre-IND Meeting For COVID-19 Study Equillium Inc (NASDAQ: EQ ) announced positive interim data from the first two cohorts of the Phase 1b open label, dose escalation portion of the EQUATE study of itolizumab in acute graft-versus-host disease.
   Wichtige Kursbewegungen: Schmerzmittel-Zulassung sorgt bei Trevena für Euphorie  2020/08/10 12:27:00 BORSE ONLINE
Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:
   The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In September  2020/08/11 12:20:27 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR ) BioLife Solutions Inc (NASDAQ: BLFS ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (reacted to second-quarter results) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Fulgent Genetics Inc (NASDAQ: FLGT ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Omeros Corporation (NASDAQ: OMER ) ( announced positive results for the study of its lead asset in COVID-19) Pacira Biosciences Inc (NASDAQ: PCRX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) ( reacted to positive late-stage clinical readout) Silk Road Medical Inc (NASDAQ: SILK ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) (announced FDA nod for pain drug) Unity Biotechnology Inc (NASDAQ: UBX ) Vaxcyte Inc (NASDAQ: PCVX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 10) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) (went public Friday) Freeline Therapeutics Holdings plc ADS (NASDAQ: FRLN ) (went public Friday) Lantern Pharma Inc. (NASDAQ: LTRN ) Nkarta Inc (NASDAQ: NKTX ) Recro Pharma Inc (NASDAQ: REPH ) (reacted to second-quarter results) Stocks In Focus Equillium Announces Positive Interim Data For Lead Drug, Requests Pre-IND Meeting For COVID-19 Study Equillium Inc (NASDAQ: EQ ) announced positive interim data from the first two cohorts of the Phase 1b open label, dose escalation portion of the EQUATE study of itolizumab in acute graft-versus-host disease.
   Wichtige Kursbewegungen: Schmerzmittel-Zulassung sorgt bei Trevena für Euphorie  2020/08/10 12:27:00 BORSE ONLINE
Es folgt der Börsen-Ticker zu wichtigen Kursbewegungen an den internationalen Finanzmärkten und ihren Ursachen:
   The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs  2020/08/07 11:34:07 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 6) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (announced introduction of AditxtScore for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biocept Inc (NASDAQ: BIOC ) (announced an agreement with Aegea for a highly sensitive PCR-based assay designed by the latter for detecting the COVID-19 virus) DarioHealth Corp (NASDAQ: DRIO ) Denali Therapeutics Inc (NASDAQ: DNLI )( announced selection of candidate to enter Phase 3 study in Parkinson's disease) Editas Medicine Inc (NASDAQ: EDIT )(moved on M&A speculation) Emergent Biosolutions Inc (NYSE: EBS ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Natera Inc (NASDAQ: NTRA ) PDL BioPharma Inc (NASDAQ: PDLI ) Sangamo Therapeutics Inc (NASDAQ: SGMO ) (reacted to its second-quarter results) Shockwave Medical Inc (NASDAQ: SWAV ) SurModics, Inc. (NASDAQ: SRDX )(reacted to its second-quarter results) Twist Bioscience Corp (NASDAQ: TWST ) Unity Biotechnology Inc (NASDAQ: UBX ) Zoetis Inc (NYSE: ZTS ) (reacted to its second-quarter results) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 6) Nkarta Inc (NASDAQ: NKTX ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX )(announced its second-quarter results) Stocks In Focus Zosano Clinches Distribution Deal For Investigational Migraine Patch Zosano Pharma Corp (NASDAQ: ZSAN ) said it has partnered with Eversana commercialize and distribute Qtrypta in the U.S.
   The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings  2020/08/05 11:35:15 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) ABIOMED, Inc. (NASDAQ: ABMD ) (FDA approved the emergency use of Abiomed's Impella heart pump in combination with an oxygen machine to treat Covid-19 patients who suffer heart and lung failure) Allovir Inc (NASDAQ: ALVR ) (IPOed Thursday) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced positive preclinical data for its lead drug in Multiple System Atrophy) ALX Oncology Holdings Inc (NASDAQ: ALXO ) Cardiff Oncology Inc (NASDAQ: CRDF ) Cocrystal Pharma Inc (NASDAQ: COCP ) (announced the publication of positive preclinical animal studies of coronavirus antiviral compounds in a medical journal) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Hologic, Inc. (NASDAQ: HOLX ) Inari Medical Inc (NASDAQ: NARI ) Inozyme Pharma Inc (NASDAQ: INZY ) Quidel Corporation (NASDAQ: QDEL ) Renalytix AI PLC (NASDAQ: RNLX ) Sorrento Therapeutics Inc (NASDAQ: SRNE ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Varian Medical Systems, Inc. (NYSE: VAR ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 4) Pandion Therapeutics Holdco LLC (NASDAQ: PAND ) Verrica Pharmaceuticals Inc (NASDAQ: VRCA ) Stocks In Focus Novavax Announces Positive Phase 1 Data For Coronavirus Vaccine Novavax, Inc. (NASDAQ: NVAX ) announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID 19 vaccine NVX CoV2373 with and without Matrix M adjuvant, which showed the investigational vaccine was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera.
   The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings  2020/08/02 15:08:50 Benzinga
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY ) GlaxoSmithKline plc (NYSE: GSK ) won a joint $2.1 billion U.S. federal funding award. Here're the key catalysts for the unfolding week: Conferences 72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8 PDUFA Dates FDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT ) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through. Trevena Inc (NASDAQ: TRVN ) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.

calendar